AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (903.9 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Progress and prospects of 18F-FDG PET/CT in liver metastases

Qing SUN, Di LIANG, Jian HE ( )
Department of Nuclear Medicine, Drum Tower Clinical Medical College, Nanjing Medical University, Nanjing 210008, China
Show Author Information

Abstract

The liver is a common site for tumor metastases. Liver metastases often occur secondary to malignancies including colorectal cancer, pancreatic cancer, melanoma, lung cancer, and breast cancer, accounting for nearly 25% of all cancer metastases, and the 1-year survival rate for all patients with liver metastases is 15.1%. Early diagnosis and precise treatment are crucial for improving patient prognosis. As an imaging technique that combines functional metabolism with anatomical structure, 18F-fluoro-deoxy-D-glucose (18F-FDG) PET/CT plays an increasingly important role in the diagnosis, staging, and treatment planning of liver metastases. This article reviews recent advances in 18F-FDG PET/CT research on liver metastases, including its applications in diagnosis, differential diagnosis, pre-treatment evaluation, efficacy assessment, and prognosis prediction; its advantages and disadvantages in comparative imaging; new technological developments such as delayed imaging and image optimization; diagnostic pitfalls in certain diseases; and its role in guiding radiotherapy. Finally, it summarizes the application of artificial intelligence technology in the diagnosis and treatment of liver metastases and provides prospects on the future development directions of 18F-FDG PET/CT in this field.

CLC number: R735.7; R730.44 Document code: A Article ID: 1007-4368(2026)06-799-10

References

【1】
【1】
 
 
Journal of Nanjing Medical University (Natural Sciences)
Pages 799-808

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
SUN Q, LIANG D, HE J. Progress and prospects of 18F-FDG PET/CT in liver metastases. Journal of Nanjing Medical University (Natural Sciences), 2026, 46(6): 799-808. https://doi.org/10.7655/NYDXBNSN251477

4

Views

0

Downloads

0

Crossref

Received: 27 December 2025
Revised: 06 February 2026
Accepted: 05 March 2026
Published: 15 June 2026
© 2026 Editorial Board of Journal of Nanjing Medical University(Natural Sciences)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).